BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 3932474)

  • 1. Vitamin K-dependent carboxylation and vitamin K metabolism in liver. Effects of warfarin.
    Wallin R; Martin LF
    J Clin Invest; 1985 Nov; 76(5):1879-84. PubMed ID: 3932474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin K-dependent carboxylation in the developing rat: evidence for a similar mechanism of action of warfarin in fetal and adult livers.
    Wallin R
    Pediatr Res; 1989 Oct; 26(4):370-6. PubMed ID: 2508052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of coumarin action: sensitivity of vitamin K metabolizing enzymes of normal and warfarin-resistant rat liver.
    Hildebrandt EF; Suttie JW
    Biochemistry; 1982 May; 21(10):2406-11. PubMed ID: 6807339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin K antagonism of coumarin intoxication in the rat.
    Wallin R; Patrick SD; Ballard JO
    Thromb Haemost; 1986 Apr; 55(2):235-9. PubMed ID: 2424118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Methylcholanthrene induction of enzymes in the vitamin K-dependent carboxylation system.
    Wallin R; Patrick SD; Martin LF
    Biochem Pharmacol; 1987 Dec; 36(24):4303-6. PubMed ID: 3120735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro inhibition of vitamin K dependent carboxylation by tetrachloropyridinol and the imidazopyridines.
    Friedman PA; Griep AE
    Biochemistry; 1980 Jul; 19(14):3381-6. PubMed ID: 6773541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that warfarin anticoagulant action involves two distinct reductase activities.
    Fasco MJ; Hildebrandt EF; Suttie JW
    J Biol Chem; 1982 Oct; 257(19):11210-2. PubMed ID: 6811577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin K-dependent carboxylation. Evidence that at least two microsomal dehydrogenases reduce vitamin K1 to support carboxylation.
    Wallin R; Hutson S
    J Biol Chem; 1982 Feb; 257(4):1583-6. PubMed ID: 6799508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warfarin poisoning and vitamin K antagonism in rat and human liver. Design of a system in vitro that mimics the situation in vivo.
    Wallin R; Martin LF
    Biochem J; 1987 Jan; 241(2):389-96. PubMed ID: 3593198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin K metabolism and vitamin K1 status in human liver samples: a search for inter-individual differences in warfarin sensitivity.
    Thijssen HH; Drittij-Reijnders MJ
    Br J Haematol; 1993 Aug; 84(4):681-5. PubMed ID: 8217828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin and the vitamin K-dependent gamma-carboxylation system.
    Wallin R; Hutson SM
    Trends Mol Med; 2004 Jul; 10(7):299-302. PubMed ID: 15242675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disulfide-dependent protein folding is linked to operation of the vitamin K cycle in the endoplasmic reticulum. A protein disulfide isomerase-VKORC1 redox enzyme complex appears to be responsible for vitamin K1 2,3-epoxide reduction.
    Wajih N; Hutson SM; Wallin R
    J Biol Chem; 2007 Jan; 282(4):2626-35. PubMed ID: 17124179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin K-dependent carboxylation and vitamin K epoxidation. Evidence that the warfarin-sensitive microsomal NAD(P)H dehydrogenase reduces vitamin K1 in these reactions.
    Wallin R; Suttie JW
    Biochem J; 1981 Mar; 194(3):983-8. PubMed ID: 7306037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between the vitamin K cycle inhibition and the plasma anticoagulant response at steady-state S-warfarin conditions in the rat.
    Mosterd JJ; Thijssen HH
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1081-5. PubMed ID: 1545379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitory effect of calumenin on the vitamin K-dependent gamma-carboxylation system. Characterization of the system in normal and warfarin-resistant rats.
    Wajih N; Sane DC; Hutson SM; Wallin R
    J Biol Chem; 2004 Jun; 279(24):25276-83. PubMed ID: 15075329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin K 2,3-epoxide reductase and the vitamin K-dependent gamma-carboxylation system.
    Wallin R; Sane DC; Hutson SM
    Thromb Res; 2002 Nov; 108(4):221-6. PubMed ID: 12617985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of 3-hydroxy-2,3-dihydrovitamin K1 in vivo: relationship to vitamin K epoxide reductase and warfarin resistance.
    Preusch PC; Suttie JW
    J Nutr; 1984 May; 114(5):902-10. PubMed ID: 6726460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vitamin K-dependent carboxylation system in human osteosarcoma U2-OS cells. Antidotal effect of vitamin K1 and a novel mechanism for the action of warfarin.
    Wallin R; Rossi F; Loeser R; Key LL
    Biochem J; 1990 Jul; 269(2):459-64. PubMed ID: 2386486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vivo effects of acenocoumarol, phenprocoumon and warfarin on vitamin K epoxide reductase and vitamin K-dependent carboxylase in various tissues of the rat.
    de Boer-van den Berg MA; Thijssen HH; Vermeer C
    Biochim Biophys Acta; 1986 Oct; 884(1):150-7. PubMed ID: 3490277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assembly of the warfarin-sensitive vitamin K 2,3-epoxide reductase enzyme complex in the endoplasmic reticulum membrane.
    Cain D; Hutson SM; Wallin R
    J Biol Chem; 1997 Nov; 272(46):29068-75. PubMed ID: 9360981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.